Heart Failure in the Era of Precision Medicine

Published: September 12, 2019

DNA showing double helix research concept
  • One in five people in the U.S. will develop heart failure (HF) in their lifetime
  • Early diagnosis and better understanding of HF pathophysiology are critical to optimal treatment and outcomes.
  • This statement describes the current state of the “omics” — genomics, pharmacogenomics, epigenomics, proteomics, metabolomics, and microbiomics — as they relate to HF and explores current and potential applications of “omics” data for precision medicine.